BHV3000-406: A Phase 4, Randomized, Doubleblind Placebo-Controlled, Efficacy and TolerabilityTrial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use (NCT05509400)
BHV3000-406
This trial is No longer recruiting
Registration number NCT05509400
Program & service
This trial is being run with the Brain service, and as part of the Neurology program.
Trial phase
Phase 4
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Jason Ray
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR